Review article: randomised controlled trials in inflammatory bowel disease-common challenges and potential solutions.

Schreiber S, Irving PM, Sharara AI, Martín-Arranz MD, Hébuterne X, Penchev P, Danese S, Anthopoulos P, Akhundova-Unadkat G, Baert F

Open source

DOI
10.1111/apt.16781
Published
2022 Mar
Container
Alimentary pharmacology & therapeutics
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/apt.16781,
  title = {Review article: randomised controlled trials in inflammatory bowel disease-common challenges and potential solutions.},
  author = {Schreiber S and Irving PM and Sharara AI and Martín-Arranz MD and Hébuterne X and Penchev P and Danese S and Anthopoulos P and Akhundova-Unadkat G and Baert F},
  year = {2022},
  journal = {Alimentary pharmacology \& therapeutics},
  doi = {10.1111/apt.16781},
  url = {https://doi.org/10.1111/apt.16781}
}

RIS

TY  - JOUR
TI  - Review article: randomised controlled trials in inflammatory bowel disease-common challenges and potential solutions.
AU  - Schreiber S
AU  - Irving PM
AU  - Sharara AI
AU  - Martín-Arranz MD
AU  - Hébuterne X
AU  - Penchev P
AU  - Danese S
AU  - Anthopoulos P
AU  - Akhundova-Unadkat G
AU  - Baert F
PY  - 2022
JO  - Alimentary pharmacology & therapeutics
DO  - 10.1111/apt.16781
UR  - https://doi.org/10.1111/apt.16781
ER  - 

APA

S, S., PM, I., AI, S., MD, M., X, H., P, P., S, D., P, A., G, A., & F, B. (2022). Review article: randomised controlled trials in inflammatory bowel disease-common challenges and potential solutions.. Alimentary pharmacology & therapeutics. https://doi.org/10.1111/apt.16781

Source records